Western blotting and immunohistochemistry showed that the expression of the EXO marker, CD63, was up-regulated in renal cortex and glomeruli, respectively, indicating that the secretion of EXOs in the LPS-AKI model was increased (Fig. 2g, i). This evidence concerns the gene CD63 and acute kidney injury.